Tuberculosis and Respiratory Diseases

Non-pharmacological Treatment for Nontuberculous Mycobacterial Pulmonary Disease: Hyung-Jun Kim; Received March 8, 2024 Accepted April 24, 2024 Published online April 25, 2024; DOI: https://doi.org/10.4046/trd.2024.0033 [Accepted]; PDF

Inappropriate Peak Inspiratory Flow Rate in the Patients with Stable Chronic Obstructive Pulmonary Disease in Korea: Seong Hwan Youn, Hyun Jung Kim, Jae Seok Park, Sun Hyo Park, Yong Shik Kwon, Mi-Ae Kim; Received December 20, 2023 Accepted April 23, 2024 Published online April 25, 2024; DOI: https://doi.org/10.4046/trd.2023.0195 [Accepted]; PDF

Bioinformatics study and experimental evaluation of miR-182, and miR-34 expression profiles in Tuberculosis and lung cancer: Leila Alimardanian, Bahram Mohammad Soltani, Shiva Irani, Mojgan Sheikhpour; Received October 23, 2023 Accepted April 7, 2024 Published online April 15, 2024; DOI: https://doi.org/10.4046/trd.2023.0172 [Accepted]; PDF

Public-Private Partnership for TB care and prevention in Korea: Jinsoo Min, Yoolwon Jeong; Received February 19, 2024 Accepted April 7, 2024 Published online April 9, 2024; DOI: https://doi.org/10.4046/trd.2024.0022 [Accepted]; PDF

Epidemiological Characteristics of Nontuberculous Mycobacterial Pulmonary Disease in South Korea: A Meta-Analysis of Individual Participant Data: Geunin Lee, Sol Kim, Shihwan Chang, Hojoon Sohn, Young Ae Kang, Youngmok Park; Received December 13, 2023 Accepted April 7, 2024 Published online April 9, 2024; DOI: https://doi.org/10.4046/trd.2023.0193 [Accepted]; PDF

EFFECTS OF THE USE OF BETA-BLOCKERS ON CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) ASSOCIATED WITH CARDIOVASCULAR COMORBITIES: SYSTEMATIC REVIEW AND META-ANALYSIS: Natasha Cordeiro dos Santos, Aquiles Assunção Camelier, Anne Karine Menezes, Victor Durier Cavalcanti de Almeida, Roberto Rodrigues Bandeira Tosta Maciel, Fernanda Warken Rosa Camelier; Received January 27, 2024 Accepted March 29, 2024 Published online April 4, 2024; DOI: https://doi.org/10.4046/trd.2024.0013 [Accepted]; PDF

Contemporary Strategies: Incorporating Immunotherapy into Stage III Non-Small Cell Lung Cancer Treatment: Da Hyun Kang, Chaeuk Chung; Received October 8, 2023 Accepted March 22, 2024 Published online March 28, 2024; DOI: https://doi.org/10.4046/trd.2023.0162 [Accepted]; PDF

Big Data Research on Severe Asthma: Sang Hyuk Kim, Youlim Kim; Received November 18, 2023 Accepted February 29, 2024 Published online March 5, 2024; DOI: https://doi.org/10.4046/trd.2023.0186 [Accepted]; PDF

Advanced bronchoscopic diagnostic techniques in lung cancer: Dongil Park; Received October 6, 2023 Accepted February 22, 2024 Published online February 28, 2024; DOI: https://doi.org/10.4046/trd.2023.0147 [Accepted]; PDF

9,557	The Importance of Early Chronic Obstructive Pulmonary Disease: A Lecture from 2022 Asian Pacific Society of Respirology
4,376	Subphenotypes of Acute Respiratory Distress Syndrome: Advancing Towards Precision Medicine
2,559	Early Mobilization and Rehabilitation of Critically-Ill Patients
14,790	Concise Clinical Review of Hematologic Toxicity of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Role of Mitochondria
2,331	Association between Antacid Exposure and Risk of Interstitial Lung Diseases

Cited By 26	Prevalence and Impact of Comorbidities in Individuals with Chronic Obstructive Pulmonary Disease: A Systematic Review
Cited By 14	Tuberculosis: Republic of Korea, 2021
Cited By 12	Clinical Features, Diagnosis, Management, and Outcomes of Idiopathic Pulmonary Fibrosis in Korea: Analysis of the Korea IPF Cohort (KICO) Registry
Cited By 10	Concise Clinical Review of Hematologic Toxicity of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Role of Mitochondria
Cited By 10	Pulmonary Functions and Inflammatory Biomarkers in Post-Pulmonary Tuberculosis Sequelae

Accepted articles